Literature DB >> 15378053

Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance.

Sally M Blower1, Tom Chou.   

Abstract

'Hot zones' are areas that have >5% prevalence (or incidence) of multidrug-resistant tuberculosis (MDRTB). We present a new mathematical model (the amplifier model) that tracks the emergence and evolution of multiple (pre-MDR, MDR and post-MDR) strains of drug-resistant Mycobacterium tuberculosis. We reconstruct possible evolutionary trajectories that generated hot zones over the past three decades, and identify the key causal factors. Results are consistent with recently reported World Health Organization (WHO) data. Our analyses yield three important insights. First, paradoxically we found that areas with programs that successfully reduced wild-type pansensitive strains often evolved into hot zones. Second, some hot zones emerged even when MDR strains were substantially less fit (and thus less transmissible) than wild-type pansensitive strains. Third, levels of MDR are driven by case-finding rates, cure rates and amplification probabilities. To effectively control MDRTB in the hot zones, it is essential that the WHO specify a goal for minimizing the amplification probability.

Entities:  

Mesh:

Year:  2004        PMID: 15378053     DOI: 10.1038/nm1102

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  56 in total

Review 1.  Perspectives on the basic reproductive ratio.

Authors:  J M Heffernan; R J Smith; L M Wahl
Journal:  J R Soc Interface       Date:  2005-09-22       Impact factor: 4.118

2.  Stochastic model of an influenza epidemic with drug resistance.

Authors:  Yaji Xu; Linda J S Allen; Alan S Perelson
Journal:  J Theor Biol       Date:  2007-05-17       Impact factor: 2.691

3.  Management of drug resistance in the population: influenza as a case study.

Authors:  Seyed M Moghadas
Journal:  Proc Biol Sci       Date:  2008-05-22       Impact factor: 5.349

Review 4.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

Review 5.  Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis.

Authors:  Christopher Dye
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 6.  The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Borna Müller; Sonia Borrell; Graham Rose; Sebastien Gagneux
Journal:  Trends Genet       Date:  2012-12-13       Impact factor: 11.639

7.  High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.

Authors:  Desiree T B D'souza; Nerges F Mistry; Tina S Vira; Yatin Dholakia; Sven Hoffner; Geoffrey Pasvol; Mark Nicol; Robert J Wilkinson
Journal:  BMC Public Health       Date:  2009-06-29       Impact factor: 3.295

8.  Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB.

Authors:  Jason D Bishai; William R Bishai; David M Bishai
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

9.  Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.

Authors:  E Green; C L Obi; M Nchabeleng; B E de Villiers; P P Sein; T Letsoalo; A A Hoosen; P O Bessong; R N Ndip
Journal:  J Health Popul Nutr       Date:  2010-02       Impact factor: 2.000

Review 10.  The past and future of tuberculosis research.

Authors:  Iñaki Comas; Sebastien Gagneux
Journal:  PLoS Pathog       Date:  2009-10-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.